ArticleJournal of neuro-oncology2022

CRISPR/Cas9-mediated abrogation of CD95L/CD95 signaling-induced glioma cell growth and immunosuppression increases survival in murine glioma models.

Clara Quijano-Rubio et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.